¼¼°èÀÇ ¸é¿ª±Û·ÎºÒ¸° E(IgE) ¾Ë·¹¸£±â Ç÷¾× °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2025
»óǰÄÚµå : 1704583
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,371,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,209,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 12,048,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸é¿ª±Û·ÎºÒ¸° E(IgE) ¾Ë·¹¸£±â Ç÷¾× °Ë»ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È °­·ÂÇÑ ¼ºÀå¼¼¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2029³â±îÁö ¿¬Æò±Õ 8.5%ÀÇ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÏ¿© 501¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº ¾Ë·¹¸£±â ¿¬±¸ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ÇöÀå °Ë»ç µµÀÔ È®´ë, Á¶±â Áø´Ü ¹× °³ÀÔ¿¡ ´ëÇÑ °ü½É Áõ°¡, Á¾ÇÕÀûÀÎ ¾Ë·¹¸£±â ÇÁ·ÎÆÄÀϸµ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ¾Ë·¹¸£±â Áø´Ü¿¡ ´ëÇÑ ÀΰøÁö´ÉÀÇ ÅëÇÕ µî¿¡ ±âÀÎÇÕ´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ¸ÖƼÇ÷º½º ¾Ë·¹¸£±â °Ë»çÀÇ µîÀå, ¾Ë·¹¸£±â »ó´ã¿¡ ¿ø°ÝÀÇ·á Ȱ¿ë, ¾Ë·¹¸£±â ÁúȯÀÇ »õ·Î¿î ¹ÙÀÌ¿À¸¶Ä¿ °³¹ß, ¼ÒºñÀÚ Á÷Á¢ ¾Ë·¹¸£±â °Ë»ç ¼­ºñ½º È®´ë, ¸ÂÃãÇü ¾Ë·¹¸£±â °ü¸®¸¦ À§ÇÑ ºòµ¥ÀÌÅÍ ºÐ¼®ÀÇ ÅëÇÕ µîÀ» ²ÅÀ» ¼ö ÀÖ½À´Ï´Ù.

¾Ë·¹¸£±â À¯º´·üÀÇ Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È IgE ¾Ë·¹¸£±â Ç÷¾× °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¾Ë·¹¸£±â´Â ÀϹÝÀûÀ¸·Î ´ëºÎºÐÀÇ »ç¶÷µé¿¡°Ô ¹«ÇØÇÑ ¹°Áú¿¡ ´ëÇØ ¸é¿ª ü°è°¡ °úµµÇÏ°Ô ¹ÝÀÀÇÏ¿© Àçä±â, °¡·Á¿òÁõ, È£Èí±âÁúȯ°ú °°Àº Áõ»óÀ» À¯¹ßÇÏ¿© ¹ß»ýÇÕ´Ï´Ù. ¾Ë·¹¸£±â ȯÀÚÀÇ Áõ°¡´Â »ýȰ½À°üÀÇ º¯È­, ȯ°æ¿À¿°, À¯ÀüÀû ¿äÀο¡ ±âÀÎÇÏ´Â °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, IgE ¾Ë·¹¸£±â Ç÷¾×°Ë»ç´Â Ç÷¾× ³» ¸é¿ª±Û·Îºí¸° E(IgE) Ç×üÀÇ ³óµµ¸¦ ÃøÁ¤ÇÏ¿© ƯÁ¤ ¾Ë·¹¸£°ÕÀ» È®ÀÎÇÏ´Â °ÍÀ¸·Î õ½Ä, ¾Ë·¹¸£±â ºñ¿°, À½½Ä¹° ¾Ë·¹¸£±â µî ¾Ë·¹¸£±â ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ Ȱ¿ëµÇ°í ÀÖ½À´Ï´Ù. µîÀÇ ¾Ë·¹¸£±â ÁúȯÀ» Áø´ÜÇÏ°í °ü¸®ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ õ½Ä ¹× ¾Ë·¹¸£±â Àç´ÜÀÌ 2022³â 3¿ù ¹ßÇ¥ÇÑ 'AAFA 2022 Allergy Capitals Report'¿¡ µû¸£¸é, ÀϹÝÀûÀ¸·Î ²É°¡·ç ¾Ë·¹¸£±â·Î ¾Ë·ÁÁø °èÀý¼º ¾Ë·¹¸£±â¼º ºñ¿°Àº °¡Àå ³Î¸® ÆÛÁø ¾Ë·¹¸£±â Áúȯ Áß ÇϳªÀÔ´Ï´Ù. ¼ºÀÎÀÇ ¾à 7.7%, ¼Ò¾ÆÀÇ ¾à 7.2%°¡ ÀÌ ÁúȯÀ¸·Î Áø´Ü¹Þ°í ÀÖ½À´Ï´Ù. µû¶ó¼­ ¾Ë·¹¸£±â À¯º´·üÀÇ Áõ°¡°¡ IgE ¾Ë·¹¸£±â Ç÷¾×°Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

IgE ¾Ë·¹¸£±â Ç÷¾× °Ë»ç ½ÃÀåÀÇ Çõ½ÅÀº ¾Ë·¹¸£±â Áø´ÜÀÇ Á¤È®¼º, È¿À²¼º, È®À强À» ³ôÀ̱â À§ÇÑ AI ±â¹Ý ¾Ë·¹¸£±â °Ë»ç °³¹ß¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °Ë»ç´Â ÀΰøÁö´É ¾Ë°í¸®Áò°ú ¸Ó½Å·¯´× ±â¼úÀ» Ȱ¿ëÇÏ¿© ¾Ë·¹¸£±â °ü·Ã µ¥ÀÌÅ͸¦ ºÐ¼®ÇÏ¿© °³ÀÎÀÇ ¾Ë·¹¸£±â ¹Î°¨µµ¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, Dr. Dangs LabÀº ³ª³ëÀÔÀÚ¸¦ ÀÌ¿ëÇÑ ¸¶ÀÌÅ©·Î¾î·¹ÀÌ ±â¹ÝÀÇ ºÐÀÚ ¾Ë·¹¸£±â Áø´Ü °Ë»ç 'Allergynius Dx'¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ´Â ¾Ë·¹¸£±â °Ë»çÀÇ Å« ÁøÀüÀ» ÀǹÌÇϸç, ±¤¹üÀ§ÇÑ ¾Ë·¹¸£°Õ¿¡ ´ëÇÑ ¾Ë·¹¸£±â¸¦ ½Äº°ÇÏ°í °ü¸®ÇÒ ¼ö ÀÖ´Â Á¾ÇÕÀûÀÎ Á¢±Ù¹ýÀ» Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ½ÅÁ¾ Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ, ±×¸®°í °æ±âȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°¡¤±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷°ú Çõ½ÅÀû ±â¾÷

Á¦32Àå ¼¼°èÀÇ ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´

Á¦34Àå ÃÖ±ÙÀÇ ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Immunoglobulin E (IgE) allergy blood tests are designed to measure the levels of IgE antibodies present in the bloodstream, which are generated by the immune system in response to allergens. These tests play a crucial role in identifying the particular allergens responsible for triggering allergic reactions in individuals. Healthcare providers rely on these test results to pinpoint the allergens causing allergic symptoms, enabling them to tailor treatment plans accordingly and thereby improving patient management and overall quality of life.

The primary product categories of IgE allergy blood tests include assays and kits, which comprise enzyme-linked immunosorbent assay (ELISA) testing kits, fluorescent enzyme immunoassays (FEIA) testing kits, and chemiluminescent immunoassays (CLIA). These kits and assays consist of tools and substances utilized to analyze biological samples for specific allergens or conditions. They serve diverse applications, encompassing aero allergies, indoor allergies, outdoor allergies, food allergies, venoms, medicine allergies, and latex/metal allergies. End users of these products span diagnostic laboratories, specialty clinics, hospitals, and research and academic centers, reflecting a wide array of healthcare and scientific facilities.

The immunoglobulin E (IgE) allergy blood tests market research report is one of a series of new reports from The Business Research Company that provides immunoglobulin E (IgE) allergy blood tests market statistics, including the immunoglobulin E (IgE) allergy blood tests industry global market size, regional shares, competitors with immunoglobulin E (IgE) allergy blood tests market share, detailed immunoglobulin E (IgE) allergy blood tests market segments, market trends, and opportunities, and any further data you may need to thrive in the immunoglobulin E (IgE) allergy blood tests industry. This immunoglobulin E (IgE) allergy blood tests market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunoglobulin e (IgE) allergy blood tests market size has grown strongly in recent years. It will grow from $33.24 billion in 2024 to $36.19 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to technological advancements, increasing allergy prevalence, growing demand for personalized medicine, expanding healthcare infrastructure, and rising awareness about allergy diagnosis and treatment.

The immunoglobulin e (IgE) allergy blood tests market size is expected to see strong growth in the next few years. It will grow to $50.11 billion in 2029 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising investments in allergy research and development, expanding adoption of point-of-care testing, increasing focus on early diagnosis and intervention, growing demand for comprehensive allergy profiling, and integration of artificial intelligence in allergy diagnostics. Major trends in the forecast period include emergence of multiplex allergy testing, utilization of telemedicine for allergy consultations, development of novel biomarkers for allergic diseases, expansion of direct-to-consumer allergy testing services, and integration of big data analytics for personalized allergy management.

The growing prevalence of allergies is expected to drive the growth of the IgE allergy blood tests market in the coming years. Allergies occur when the immune system reacts excessively to substances that are usually harmless to most people, leading to symptoms such as sneezing, itching, and respiratory problems. The rise in allergy cases can be attributed to lifestyle changes, environmental pollution, and genetic factors. IgE allergy blood tests are used to identify specific allergens by measuring the levels of Immunoglobulin E (IgE) antibodies in the blood, which helps in diagnosing and managing allergic conditions like asthma, allergic rhinitis, and food allergies. For example, according to the AAFA 2022 Allergy Capitals Report released by the Asthma and Allergy Foundation of America in March 2022, seasonal allergic rhinitis, commonly known as hay fever, is among the most widespread allergic conditions. Approximately 7.7% of adults and 7.2% of children have been diagnosed with this condition. Thus, the increasing prevalence of allergies is fueling the growth of the IgE allergy blood tests market.

Innovations in the IgE allergy blood test market focus on developing AI-powered allergy tests to enhance accuracy, efficiency, and scalability in allergy diagnostics. These tests leverage artificial intelligence algorithms and machine learning techniques to analyze allergy-related data and provide valuable insights into individual allergic sensitivities. For example, Dr. Dangs Lab introduced 'Allergynius Dx,' a molecular allergy diagnostics test based on Microarray using Nano Particles, capable of testing 163 food and respiratory allergens. This advancement signifies a significant leap in allergy testing, offering a comprehensive approach to identifying and managing allergies across a broad spectrum of allergens.

In October 2022, Sebia, a France-based provider of equipment and reagents for clinical protein electrophoresis, acquired Zeus Scientific Inc. for an undisclosed amount. This acquisition is intended to enhance Sebia's product range and expand its market footprint in the United States. By incorporating Zeus Scientific's expertise in immunofixation electrophoresis and related diagnostics, Sebia aims to strengthen its portfolio within the clinical laboratory sector. Zeus Scientific Inc. is a US-based manufacturer of medical equipment.

Major companies operating in the immunoglobulin E (IgE) allergy blood tests market are Roche Holdings Inc., Thermo Fisher Scientific Inc, Abbott Laboratories, Novartis AG, Siemens Healthineers Pvt Ltd, BD Biosciences, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, BioMerieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Bio-Techne Corporation, GenScript Biotech Corporation, Randox Laboratories Ltd, Neogen Corporation, Invitae Corporation, Quanterix Corporation, Omega Diagnostics Plc, AESKU Group GmbH, Hitachi Chemical Diagnostics Inc., HYCOR Biomedical LLC, Amerimmune LLC

North America was the largest region in the immunoglobulin E (IgE) allergy blood tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulin E (IgE) allergy blood tests market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the immunoglobulin E (IgE) allergy blood tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The immunoglobulin E (IgE) allergy blood tests market consists of sales of custom panels, and component-resolved diagnostics (CRD). Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoglobulin E (IgE) Allergy Blood Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoglobulin e (ige) allergy blood tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for immunoglobulin e (ige) allergy blood tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunoglobulin e (ige) allergy blood tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Immunoglobulin E (IgE) Allergy Blood Tests Market Characteristics

3. Immunoglobulin E (IgE) Allergy Blood Tests Market Trends And Strategies

4. Immunoglobulin E (IgE) Allergy Blood Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Immunoglobulin E (IgE) Allergy Blood Tests Growth Analysis And Strategic Analysis Framework

6. Immunoglobulin E (IgE) Allergy Blood Tests Market Segmentation

7. Immunoglobulin E (IgE) Allergy Blood Tests Market Regional And Country Analysis

8. Asia-Pacific Immunoglobulin E (IgE) Allergy Blood Tests Market

9. China Immunoglobulin E (IgE) Allergy Blood Tests Market

10. India Immunoglobulin E (IgE) Allergy Blood Tests Market

11. Japan Immunoglobulin E (IgE) Allergy Blood Tests Market

12. Australia Immunoglobulin E (IgE) Allergy Blood Tests Market

13. Indonesia Immunoglobulin E (IgE) Allergy Blood Tests Market

14. South Korea Immunoglobulin E (IgE) Allergy Blood Tests Market

15. Western Europe Immunoglobulin E (IgE) Allergy Blood Tests Market

16. UK Immunoglobulin E (IgE) Allergy Blood Tests Market

17. Germany Immunoglobulin E (IgE) Allergy Blood Tests Market

18. France Immunoglobulin E (IgE) Allergy Blood Tests Market

19. Italy Immunoglobulin E (IgE) Allergy Blood Tests Market

20. Spain Immunoglobulin E (IgE) Allergy Blood Tests Market

21. Eastern Europe Immunoglobulin E (IgE) Allergy Blood Tests Market

22. Russia Immunoglobulin E (IgE) Allergy Blood Tests Market

23. North America Immunoglobulin E (IgE) Allergy Blood Tests Market

24. USA Immunoglobulin E (IgE) Allergy Blood Tests Market

25. Canada Immunoglobulin E (IgE) Allergy Blood Tests Market

26. South America Immunoglobulin E (IgE) Allergy Blood Tests Market

27. Brazil Immunoglobulin E (IgE) Allergy Blood Tests Market

28. Middle East Immunoglobulin E (IgE) Allergy Blood Tests Market

29. Africa Immunoglobulin E (IgE) Allergy Blood Tests Market

30. Immunoglobulin E (IgE) Allergy Blood Tests Market Competitive Landscape And Company Profiles

31. Immunoglobulin E (IgE) Allergy Blood Tests Market Other Major And Innovative Companies

32. Global Immunoglobulin E (IgE) Allergy Blood Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoglobulin E (IgE) Allergy Blood Tests Market

34. Recent Developments In The Immunoglobulin E (IgE) Allergy Blood Tests Market

35. Immunoglobulin E (IgE) Allergy Blood Tests Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â